scholarly journals Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis

2022 ◽  
Vol 13 (1) ◽  
Author(s):  
Xiao-Na Xiang ◽  
Si-Yi Zhu ◽  
Hong-Chen He ◽  
Xi Yu ◽  
Yang Xu ◽  
...  

AbstractOsteoarthritis, as a degenerative disease, is a common problem and results in high socioeconomic costs and rates of disability. The most commonly affected joint is the knee and characterized by progressive destruction of articular cartilage, loss of extracellular matrix, and progressive inflammation. Mesenchymal stromal cell (MSC)-based therapy has been explored as a new regenerative treatment for knee osteoarthritis in recent years. However, the detailed functions of MSC-based therapy and related mechanism, especially of cartilage regeneration, have not been explained. Hence, this review summarized how to choose, authenticate, and culture different origins of MSCs and derived exosomes. Moreover, clinical application and the latest mechanistical findings of MSC-based therapy in cartilage regeneration were also demonstrated.

2019 ◽  
Vol 10 ◽  
Author(s):  
Henry Caplan ◽  
Scott D. Olson ◽  
Akshita Kumar ◽  
Mitchell George ◽  
Karthik S. Prabhakara ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-16 ◽  
Author(s):  
Shuangpeng Jiang ◽  
Weimin Guo ◽  
Guangzhao Tian ◽  
Xujiang Luo ◽  
Liqing Peng ◽  
...  

Hyaline articular cartilage lacks blood vessels, lymphatics, and nerves and is characterised by limited self-repair ability following injury. Traditional techniques of articular cartilage repair and regeneration all have certain limitations. The development of tissue engineering technology has brought hope to the regeneration of articular cartilage. The strategies of tissue-engineered articular cartilage can be divided into three types: “cell-scaffold construct,” cell-free, and scaffold-free. In “cell-scaffold construct” strategies, seed cells can be autologous chondrocytes or stem. Among them, some commercial products with autologous chondrocytes as seed cells, such as BioSeed®-C and CaReS®, have been put on the market and some products are undergoing clinical trials, such as NOVOCART® 3D. The stem cells are mainly pluripotent stem cells and mesenchymal stem cells from different sources. Cell-free strategies that indirectly utilize the repair and regeneration potential of stem cells have also been used in clinical settings, such as TruFit and MaioRegen. Finally, the scaffold-free strategy is also a new development direction, and the short-term repair results of related products, such as NOVOCART® 3D, are encouraging. In this paper, the commonly used techniques of articular cartilage regeneration in surgery are reviewed. By studying different strategies and different seed cells, the clinical application status of tissue-engineered articular cartilage is described in detail.


Cytotherapy ◽  
2015 ◽  
Vol 17 (7) ◽  
pp. 860-873 ◽  
Author(s):  
Mizuho Kittaka ◽  
Mikihito Kajiya ◽  
Hideki Shiba ◽  
Manabu Takewaki ◽  
Kei Takeshita ◽  
...  

2015 ◽  
Vol 24 (6) ◽  
pp. 677-685 ◽  
Author(s):  
Maria Luisa Torre ◽  
Enrico Lucarelli ◽  
Simona Guidi ◽  
Maura Ferrari ◽  
Giulio Alessandri ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document